FIELD: medicine, pharmaceutics.
SUBSTANCE: claimed are: application of silibinin component of general formula 
(I) for obtaining medication for parenteral introduction for trweatment of viral hepatitis, with medication optionally containing cyclodextrin and/or phospholipid, and set of similar purpose, which includes said silibinin component and other medication, representing one or several pharmaceutical agents from: arginine, glutamate, silymarin, citiolone, epodemiol, ornithine oxoglurate, tidiacic arginine, myoinosite, methionine and N-acetyl methionine, choline, ornithine aspartate, cyanidanol, thiopronin, betaine, cyanocobalamin, leucine, levolose, acyclovir, idoxuridine, vidarabine, ribavirin, ganciclovir, famciclovir, valaciclovir, cidofovir, penciclovir, valganciclovir, brivudin, interferon. Medication preferably does not contain silidianin, and/or silicristin, and/or isosilibinin.
EFFECT: reduction of viral strain and reactivation of patients after parenteral introduction of claimed silibinin component.
21 cl, 12 dwg, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PREDICTION OF KINETICS OF HEPATITIS C VIRUS IN INTERFERON-EXCLUDING TREATMENT | 2011 |
|
RU2590691C2 |
| METHOD OF TREATING VIRAL HEPATITIS C | 2012 |
|
RU2496512C1 |
| METHODS FOR IMPROVING PHARMACOKINETICS | 2010 |
|
RU2591830C2 |
| METHOD OF VIRUS INFECTION TREATMENT | 2004 |
|
RU2371195C2 |
| SINGLE NUCLEOTIDE POLYMORPHISMS FOR PREDICTING RESULTS OF TREATMENT OF HEPATIC C VIRUS INFECTION | 2011 |
|
RU2567663C2 |
| USING TYPE III PEGYLATED INTERFERONS FOR TREATING HEPATITIS C | 2009 |
|
RU2496514C2 |
| PHARMACEUTICAL HEPATOPROTECTIVE COMPOSITION AND TREATMENT METHOD | 2008 |
|
RU2391989C2 |
| PANGENOTYPIC NS5A PROTEIN INHIBITOR OF HEPATITIS C VIRUS, A PHARMACEUTICAL COMPOSITION AND METHODS FOR PREPARING AND USING | 2019 |
|
RU2723482C1 |
| SINGLE NUCLEOTIDE POLYMORPHISM ON CHROMOSOME 15 ENABLING PREDICTION OF HCV TREATMENT RESPONSES | 2012 |
|
RU2606759C2 |
| METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATMENT AND PREVENTION OF HEPATITIS C INFECTION | 2006 |
|
RU2440822C2 |
